HDAC9 and Simpson-Golabi-Behmel syndrome: While CM from differentiated Simpson-Golabi-Behmel syndrome (SGBS) cells did not change the global HDAC activities of Hep3B cells, it did however specifically increase the expression of the class I HDACs (HDAC 1, 2 and 8) at the mRNA level (Figure 1C).